Q1 2020 Neurocrine Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Q1 2020 Results Call. (Operator Instructions) Please note, this call may be recorded. I'll be standing by should you need assistance.
It is my pleasure to turn the program over to Kevin Gorman.
Thank you very much, and good afternoon, everyone, and thank you for joining us today. Here with me at Neurocrine is Todd Tushla, our Head of Investor Relations; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development Officer.
Before we get started, Todd, could you read our safe harbor statement, please?
Yes. Good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |